Ewa Paszkiewicz‐Kozik

914 total citations
57 papers, 316 citations indexed

About

Ewa Paszkiewicz‐Kozik is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Ewa Paszkiewicz‐Kozik has authored 57 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 19 papers in Genetics. Recurrent topics in Ewa Paszkiewicz‐Kozik's work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (18 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Ewa Paszkiewicz‐Kozik is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (18 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Ewa Paszkiewicz‐Kozik collaborates with scholars based in Poland, United States and Italy. Ewa Paszkiewicz‐Kozik's co-authors include Jan Walewski, Ronald M. Bukowski, Luis Moltó, Charles S. Tannenbaum, James H. Finke, Daisuke Kudo, Patricia Rayman, Grzegorz Rymkiewicz, Tanya Das and Andrzej Hellmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Ewa Paszkiewicz‐Kozik

47 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Paszkiewicz‐Kozik Poland 10 164 148 97 93 43 57 316
Matko Kalac United States 9 148 0.9× 161 1.1× 89 0.9× 220 2.4× 52 1.2× 37 423
Miki Kiyota Japan 10 93 0.6× 107 0.7× 101 1.0× 137 1.5× 49 1.1× 23 319
Bouchra Ghazi Morocco 6 176 1.1× 205 1.4× 175 1.8× 96 1.0× 25 0.6× 22 361
Aurélie Verney France 11 85 0.5× 224 1.5× 77 0.8× 71 0.8× 226 5.3× 16 334
Xiaohong Zhao China 5 130 0.8× 134 0.9× 69 0.7× 233 2.5× 22 0.5× 8 376
Manfred Ahlgrimm Germany 8 90 0.5× 58 0.4× 50 0.5× 76 0.8× 56 1.3× 17 272
M Wasik Poland 5 181 1.1× 114 0.8× 165 1.7× 109 1.2× 37 0.9× 11 341
Elena Ribakovsky Israel 8 103 0.6× 78 0.5× 50 0.5× 57 0.6× 53 1.2× 16 211
Jan Oliver Staak Germany 8 166 1.0× 219 1.5× 83 0.9× 55 0.6× 83 1.9× 13 345
Sara Morrow United States 6 243 1.5× 166 1.1× 203 2.1× 216 2.3× 103 2.4× 13 522

Countries citing papers authored by Ewa Paszkiewicz‐Kozik

Since Specialization
Citations

This map shows the geographic impact of Ewa Paszkiewicz‐Kozik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Paszkiewicz‐Kozik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Paszkiewicz‐Kozik more than expected).

Fields of papers citing papers by Ewa Paszkiewicz‐Kozik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Paszkiewicz‐Kozik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Paszkiewicz‐Kozik. The network helps show where Ewa Paszkiewicz‐Kozik may publish in the future.

Co-authorship network of co-authors of Ewa Paszkiewicz‐Kozik

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Paszkiewicz‐Kozik. A scholar is included among the top collaborators of Ewa Paszkiewicz‐Kozik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Paszkiewicz‐Kozik. Ewa Paszkiewicz‐Kozik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witkowska, Magdalena, Joanna Romejko‐Jarosińska, Agnieszka Giza, et al.. (2025). Primary Renal Lymphoma: Report of 32 Cases—A Retrospective Multicenter PLRG Analysis. Biomedicines. 13(3). 548–548.
2.
Glimelius, Ingrid, Won Seog Kim, Ewa Paszkiewicz‐Kozik, et al.. (2024). Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort a of the Multicenter, Open-Label, Phase 2 Waveline-006 Study. Blood. 144(Supplement 1). 4405–4405. 1 indexed citations
3.
4.
Paszkiewicz‐Kozik, Ewa, Sergiusz Markowicz, Jan Walewski, et al.. (2023). New molecular targets in Hodgkin and Reed-Sternberg cells. Frontiers in Immunology. 14. 7 indexed citations
5.
Zinzani, Pier Luigi, Jiřı́ Mayer, Ohad Benjamini, et al.. (2023). A phase 2 study of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B‐cell malignancies: waveLINE‐006. Hematological Oncology. 41(S2). 564–565. 2 indexed citations
6.
Fosså, Alexander, Muhıt Özcan, Yuqin Song, et al.. (2023). WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). Hematological Oncology. 41(S2). 208–209. 1 indexed citations
7.
Drozd‐Sokołowska, Joanna, Ewa Paszkiewicz‐Kozik, Marta Morawska, et al.. (2023). Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group. Annals of Hematology. 102(8). 2119–2126. 4 indexed citations
8.
Özcan, Muhıt, Yuqin Song, Seung‐Tae Lee, et al.. (2023). P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL). HemaSphere. 7(S3). e03345ef–e03345ef. 2 indexed citations
9.
Romejko‐Jarosińska, Joanna, Anna Dąbrowska‐Iwanicka, Katarzyna Domańska‐Czyż, et al.. (2022). High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up. Scientific Reports. 12(1). 10551–10551. 6 indexed citations
10.
Paszkiewicz‐Kozik, Ewa, Agnieszka Paziewska, Maria Kulecka, et al.. (2021). Peripheral Blood Cells from Patients with Hodgkin’s and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs. BioMed Research International. 2021(1). 3212878–3212878.
11.
Giebel, Sebastian, Wanda Knopińska‐Posłuszny, Ewa Chmielowska, et al.. (2021). High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma. Annals of Hematology. 100(7). 1755–1767.
12.
Szumera‐Ciećkiewicz, Anna, Urszula Wojciechowska, Joanna Didkowska, et al.. (2020). Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation. Scientific Reports. 10(1). 14610–14610. 10 indexed citations
13.
Szumera‐Ciećkiewicz, Anna, Jan Poleszczuk, Ewa Paszkiewicz‐Kozik, et al.. (2020). EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment. Anticancer Research. 40(12). 6685–6697. 4 indexed citations
14.
Paszkiewicz‐Kozik, Ewa, Monika Długosz‐Danecka, Paweł Robak, et al.. (2017). Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group. Blood. 130. 5217–5217. 2 indexed citations
15.
Romejko‐Jarosińska, Joanna, et al.. (2016). Outcome of primary gastrointestinal compared to nodal diffuse large B cell lymphoma in a series of consecutive patients treated at a single institution. Annals of Oncology. 27. vi314–vi314. 1 indexed citations
16.
Sokołowska‐Wojdyło, Małgorzata, Aleksandra G. Florek, Jan Maciej Zaucha, et al.. (2014). Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma. American Journal of Therapeutics. 23(3). e749–e756. 9 indexed citations
17.
Fabisiewicz, Anna, et al.. (2012). Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients. Biomedical Reports. 1(1). 151–155. 6 indexed citations
18.
Paszkiewicz‐Kozik, Ewa, Anna Fabisiewicz, Andrzej Tysarowski, et al.. (2008). Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma. Medical Oncology. 26(1). 16–21. 4 indexed citations
19.
Rymkiewicz, Grzegorz, et al.. (2006). Unusual IgD+/CD38-Follicular Lymphoma with Leukemic Presentation. Medical Oncology. 23(1). 131–136. 4 indexed citations
20.
Kudo, Daisuke, Patricia Rayman, Luis Moltó, et al.. (2004). Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas. The Journal of Immunology. 172(6). 3480–3490. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matko Kalac Breakdown of academic impact, for papers by Miki Kiyota Breakdown of academic impact, for papers by Bouchra Ghazi Breakdown of academic impact, for papers by Aurélie Verney Breakdown of academic impact, for papers by Xiaohong Zhao Breakdown of academic impact, for papers by Manfred Ahlgrimm Breakdown of academic impact, for papers by M Wasik Breakdown of academic impact, for papers by Elena Ribakovsky Breakdown of academic impact, for papers by Jan Oliver Staak Breakdown of academic impact, for papers by Sara Morrow
Rankless by CCL
2026